Open Access
Open access
volume 92 issue 10 pages RCR5096

Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action

Publication typeJournal Article
Publication date2023-11-10
scimago Q1
wos Q1
SJR0.811
CiteScore12.9
Impact factor6.0
ISSN0036021X, 14684837
General Chemistry
Abstract
The chemotherapy with cisplatin and its analogues widely used in medical practice is associated with undesirable side effects caused by non-selective ligand exchange and binding of the complexes to various biomolecules in the body. An alernative to classical platinum(II)-based drugs are platinum(IV) prodrugs, that is, platinum(II) complexes additionally modified with diverse biologically active axial ligands, including known pharmaceutical products. In recent years, quite a few studies devoted to the design of effective Pt(IV) prodrugs have been published, with some of the developed agents being markedly superior to clinically used cisplatin and carboplatin in therapeutic efficacy. This review summarizes the synthetic approaches to the design of Pt(IV) prodrugs and modification of the axial ligands. The second part of the review is devoted to the biological activity of Pt(IV) prodrugs reported in the period from 2018 to 2023 and comparison of various approaches to the design of effective anticancer agents based on these compounds.The bibliography includes 239 references.
Found 
Found 

Top-30

Journals

1
2
Mendeleev Communications
2 publications, 20%
Inorganic Chemistry
1 publication, 10%
ACS Applied Nano Materials
1 publication, 10%
Russian Journal of Oncology
1 publication, 10%
ChemMedChem
1 publication, 10%
Journal of Medicinal Chemistry
1 publication, 10%
Coordination Chemistry Reviews
1 publication, 10%
ACS Pharmacology & Translational Science
1 publication, 10%
Russian Chemical Bulletin
1 publication, 10%
1
2

Publishers

1
2
3
4
American Chemical Society (ACS)
4 publications, 40%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 20%
Eco-Vector LLC
1 publication, 10%
Wiley
1 publication, 10%
Elsevier
1 publication, 10%
Springer Nature
1 publication, 10%
1
2
3
4
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
10
Share
Cite this
GOST |
Cite this
GOST Copy
Spector D. et al. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action // Russian Chemical Reviews. 2023. Vol. 92. No. 10. p. RCR5096.
GOST all authors (up to 50) Copy
Spector D., Bubley A. A., Beloglazkina E. K., Krasnovskaya O. O. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action // Russian Chemical Reviews. 2023. Vol. 92. No. 10. p. RCR5096.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.59761/rcr5096
UR - https://rcr.colab.ws/publications/10.59761/RCR5096
TI - Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action
T2 - Russian Chemical Reviews
AU - Spector, Daniil
AU - Bubley, Anna A.
AU - Beloglazkina, Elena K.
AU - Krasnovskaya, Olga O.
PY - 2023
DA - 2023/11/10
PB - Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
SP - RCR5096
IS - 10
VL - 92
SN - 0036-021X
SN - 1468-4837
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Spector,
author = {Daniil Spector and Anna A. Bubley and Elena K. Beloglazkina and Olga O. Krasnovskaya},
title = {Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action},
journal = {Russian Chemical Reviews},
year = {2023},
volume = {92},
publisher = {Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii},
month = {nov},
url = {https://rcr.colab.ws/publications/10.59761/RCR5096},
number = {10},
pages = {RCR5096},
doi = {10.59761/rcr5096}
}
MLA
Cite this
MLA Copy
Spector, Daniil, et al. ā€œPlatinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action.ā€ Russian Chemical Reviews, vol. 92, no. 10, Nov. 2023, p. RCR5096. https://rcr.colab.ws/publications/10.59761/RCR5096.